MetaCap

NovaBridge Biosciences Insider Trades

NASDAQ: NBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.83-0.0498 (-5.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
3 · $663.18K
Sales
7 · $154.27K
Shares bought / sold
460.00K / 157.34K
Net activity
Net buying $508,909

NovaBridge Biosciences insider activity

Over the last 12 months, NovaBridge Biosciences insiders reported 19 transactions on SEC Form 4: 3 open-market purchases and 7 sales. Insiders bought $663,182 and sold $154,273 worth of stock, for net insider buying of $508,909. The largest seller was Cao Sean Wuxiong, with $122,488 in reported sales.

The most recent filing shows Hagler Mark Arnold (Chief Commercial Officer) buying 184,000 shares at $0.381 on Nov 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NBP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NBP insider transactions

NovaBridge Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Nov 18, 2026Hagler Mark ArnoldChief Commercial OfficerBuy184,000$70.10KForm 4
Nov 17, 2026Hagler Mark ArnoldChief Commercial OfficerBuy46,000$15.78KForm 4
Oct 15, 2026Woo Ian YingDirectorOption exercise13,271—Form 4
Sep 18, 2026Dennis Phillip AndrewChief Medical OfficerSale8,209$5.83KForm 4
Sep 17, 2026Dennis Phillip AndrewChief Medical OfficerOption exercise23,695—Form 4
Sep 9, 2026Cao Sean WuxiongChief Bus. Development OfficerSale107,978$79.90KForm 4
Sep 3, 2026Cao Sean WuxiongChief Bus. Development OfficerOption exercise104,236—Form 4
Sep 3, 2026Cao Sean WuxiongChief Bus. Development OfficerOption exercise235,136—Form 4
Aug 31, 2026Xu Cong ClaireEVP, Clinical DevelopmentSale3,282$2.59KForm 4
Aug 30, 2026Xu Cong ClaireEVP, Clinical DevelopmentOption exercise9,382—Form 4
Aug 22, 2026Lenz Robert A.DirectorOption exercise17,218—Form 4
Jul 6, 2026Xu Cong ClaireSVP, Clinical DevelopmentSale4,485$3.99KForm 4
Jul 4, 2026Xu Cong ClaireSVP, Clinical DevelopmentOption exercise12,432—Form 4
Jun 18, 2026Dennis Phillip AndrewChief Medical OfficerSale8,494$5.61KForm 4
Jun 17, 2026Dennis Phillip AndrewChief Medical OfficerOption exercise23,695—Form 4
Jun 1, 2026Xu Cong ClaireSVP, Clinical DevelopmentSale3,494$13.77KForm 4
May 30, 2026Xu Cong ClaireSVP, Clinical DevelopmentOption exercise9,382—Form 4
May 14, 2026Cao Sean WuxiongSee RemarksSale21,399$42.58KForm 4
Apr 24, 2026Hagler Mark ArnoldSee RemarksBuy230,000$577.30KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related